James Manuso, PhD

Chief, Financing Advisory Board

James S. J. Manuso is an entrepreneur and businessperson who founded Galenica Pharmaceuticals, Inc., PrimeTech Partners, Symbiontics, Inc. and ZyStor Therapeutics, Inc. and who has been at the head of 7 different companies. Presently, Dr. Manuso occupies the position of Chairman & Chief Executive Officer of Talfinium Investments, Inc. Dr. Manuso is also on the board of KineMed, Inc., Biotechnology Innovation Organization, OcuSub, Inc. and Ocuphire Pharma, Inc. and Managing General Partner at AAON Coil Products, Inc.

He previously held the position of Vice Chairman, President & Chief Executive Officer at RespireRx Pharmaceuticals, Inc., President of Manuso Alexander & Associates, Inc., Managing General Partner at The Channel Group, General Partner for PrimeTech Partners, Chairman & Chief Executive Officer of SuperGen, Inc., Chairman for Eurogen Ltd, Chairman & Chief Executive Officer for Astex Pharmaceuticals, Inc., President & Chief Executive Officer at Galenica Pharmaceuticals, Inc., VP, Director-Health Care Planning & Development at The Equitable Cos., Inc., Trustee & Vice President at Leukemia & Lymphoma Society Greater San Francisco Bay Area and Director at Symbiontics, Inc.

James S. J. Manuso received an undergraduate degree from New York University, a doctorate from The New School and an MBA from Columbia Business School.